278 related articles for article (PubMed ID: 30332395)
1. Basal characteristics and first year responses to human growth hormone (GH) vary according to diagnostic criteria in children with non-acquired GH deficiency (naGHD): observations from a single center over a period of five decades.
Ranke MB; Schweizer R; Binder G
J Pediatr Endocrinol Metab; 2018 Nov; 31(11):1257-1266. PubMed ID: 30332395
[TBL] [Abstract][Full Text] [Related]
2. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
3. [Establishment and validation of predictive model of short term responses to recombinant human growth hormone treatment in prepubertal short stature children with various growth hormone secretary statuses].
Su Z; Li YH; Ma HM; Chen HS; DU ML; Gu YF
Zhonghua Er Ke Za Zhi; 2008 Oct; 46(10):757-62. PubMed ID: 19099881
[TBL] [Abstract][Full Text] [Related]
4. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
Huang YH; Wai YY; Van YH; Lo FS
J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
[TBL] [Abstract][Full Text] [Related]
5. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
Esen I; Demirel F; Tepe D; Kara O; Koc N
Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
[TBL] [Abstract][Full Text] [Related]
6. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
Darendeliler F; Lindberg A; Wilton P
Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
8. Differences in serum GH cut-off values for pharmacological tests of GH secretion depend on the serum GH method. Clinical validation from the growth velocity score during the first year of treatment.
Chaler EA; Rivarola MA; Guerci B; Ciaccio M; Costanzo M; Travaglino P; Maceiras M; Pagani S; Meazza C; Bozzola E; Barberi S; Bozzola M; Belgorosky A
Horm Res; 2006; 66(5):231-5. PubMed ID: 16912509
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency.
Giovenale D; Meazza C; Cardinale GM; Farinelli E; Mastrangelo C; Messini B; Citro G; Del Vecchio M; Di Maio S; Possenti I; Bozzola M
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):433-7. PubMed ID: 18030209
[TBL] [Abstract][Full Text] [Related]
10. Plasma levels of insulin-like binding protein-2 in prepubertal short children and its diagnostic value in the evaluation of growth hormone deficiency.
van Doorn J; Ringeling AM; Rikken B; van Buul-Offers SC
Horm Res; 2001; 55(3):147-54. PubMed ID: 11549877
[TBL] [Abstract][Full Text] [Related]
11. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
12. A comparison of different definitions of growth response in short prepubertal children treated with growth hormone.
Bang P; Bjerknes R; Dahlgren J; Dunkel L; Gustafsson J; Juul A; Kriström B; Tapanainen P; Aberg V
Horm Res Paediatr; 2011; 75(5):335-45. PubMed ID: 21228552
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
Maghnie M; Strigazzi C; Tinelli C; Autelli M; Cisternino M; Loche S; Severi F
J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
[TBL] [Abstract][Full Text] [Related]
15. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
Costalonga EF; Antonini SR; Guerra-Junior G; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
[TBL] [Abstract][Full Text] [Related]
16. Retesting young adults with childhood-onset growth hormone (GH) deficiency with GH-releasing-hormone-plus-arginine test.
Aimaretti G; Baffoni C; Bellone S; Di Vito L; Corneli G; Arvat E; Benso L; Camanni F; Ghigo E
J Clin Endocrinol Metab; 2000 Oct; 85(10):3693-9. PubMed ID: 11061526
[TBL] [Abstract][Full Text] [Related]
17. IGF-I and IGF-binding protein-3 measurements on filter paper blood spots in children and adolescents on GH treatment: use in monitoring and as markers of growth performance.
Das U; Whatmore AJ; Khosravi J; Wales JK; Butler G; Kibirige MS; Diamandi A; Jones J; Patel L; Hall CM; Price DA; Clayton PE
Eur J Endocrinol; 2003 Sep; 149(3):179-85. PubMed ID: 12943519
[TBL] [Abstract][Full Text] [Related]
18. Association of the (CA)n repeat polymorphism of insulin-like growth factor-I and -202 A/C IGF-binding protein-3 promoter polymorphism with adult height in patients with severe growth hormone deficiency.
Miletta MC; Scheidegger UA; Giordano M; Bozzola M; Pagani S; Bona G; Dattani M; Hindmarsh PC; Petkovic V; Oser-Meier M; Flück CE; Mullis PE
Clin Endocrinol (Oxf); 2012 May; 76(5):683-90. PubMed ID: 22026507
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of insulin-like growth factor (IGF)-I and IGF binding protein-3 generation test in short stature.
Darendeliler F; Ocal C; Baş F
J Pediatr Endocrinol Metab; 2005 May; 18(5):443-52. PubMed ID: 15921173
[TBL] [Abstract][Full Text] [Related]
20. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
Grumbach MM; Bin-Abbas BS; Kaplan SL
Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]